Argos Therapeutics Inc (ARGS.OQ)
26 May 2015
* Shares boosted by dividend hike (Writes through, adds comments, shares)
LONDON, April 29 - Home Retail, Britain's biggest household goods retailer, said changes to its Argos business and slowing sales of technology products would make for a challenging first half of the year, as it posted a 14 percent rise in annual profit.
* Argos like-for-likes fall 5 pct, against forecast 0.2 pct fall
LONDON, March 12 - Britain's biggest household goods retailer Home Retail delivered a weaker-than-expected finish to the year at both its Argos and Homebase chains, although it said cost controls and improvements to its margin had helped the bottom line.
LONDON, Jan 29 - British general merchandise retailer Argos has struck a deal with supermarket Sainsbury's to open 10 new format digital stores within existing Sainsbury's stores.
LONDON, Jan 15 - Britain's biggest household goods retailer Home Retail missed sales forecasts for its Argos and Homebase chains over Christmas as the shopping frenzy sparked by Black Friday skewed demand later in the holiday season.
LONDON, Jan 15 - Britain's Home Retail said it expected to post full-year profit before tax in line with expectations despite underlying growth at its Argos and Homebase chains over the Christmas period missing forecasts.
- Argos Therapeutics Inc said its experimental immunotherapy was unsuccessful in treating HIV-infected patients, raising doubts about its technology platform and sending its stock plunging as much as 31 percent on Friday.
Jan 9 - Argos Therapeutics Inc said its experimental immunotherapy was unsuccessful in treating HIV-infected patients, raising doubts about its technology platform and sending its stock plunging as much as 31 percent on Friday.
Jan 9 - Argos Therapeutics Inc said its experimental drug to treat HIV failed to meet its main goal in a mid-stage study, sending the company's shares down 27 percent in premarket trade.
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
US MARKET ANALYSIS AND FORECAST. 70 PAGE REPORT PUBLISH QUARTERLY. IN EACH REPORT YOU WILL FIND 12-MONTHS FORECASTS ANALYSIS TARGET PRICE VALUATION RATINGS AND CREUDE OIL DEPENDENCE FOR 7396 US STOCKS.
Provider: Pechala's Reports
Argos Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.
Provider: ValuEngine, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.